Harmony Biosciences Holdings (HRMY) Research & Development (2019 - 2025)
Historic Research & Development for Harmony Biosciences Holdings (HRMY) over the last 7 years, with Q3 2025 value amounting to $55.0 million.
- Harmony Biosciences Holdings' Research & Development rose 11649.66% to $55.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $174.3 million, marking a year-over-year increase of 2322.98%. This contributed to the annual value of $145.8 million for FY2024, which is 9171.61% up from last year.
- According to the latest figures from Q3 2025, Harmony Biosciences Holdings' Research & Development is $55.0 million, which was up 11649.66% from $50.2 million recorded in Q2 2025.
- In the past 5 years, Harmony Biosciences Holdings' Research & Development registered a high of $63.6 million during Q2 2024, and its lowest value of $4.7 million during Q1 2021.
- Its 5-year average for Research & Development is $24.4 million, with a median of $17.5 million in 2023.
- Per our database at Business Quant, Harmony Biosciences Holdings' Research & Development tumbled by 5684.37% in 2023 and then soared by 32476.45% in 2024.
- Harmony Biosciences Holdings' Research & Development (Quarter) stood at $7.5 million in 2021, then skyrocketed by 35.44% to $10.1 million in 2022, then soared by 200.3% to $30.3 million in 2023, then grew by 14.39% to $34.7 million in 2024, then surged by 58.55% to $55.0 million in 2025.
- Its last three reported values are $55.0 million in Q3 2025, $50.2 million for Q2 2025, and $34.5 million during Q1 2025.